InspireMD, Inc. (NSPR)

1.81 +0.10 (+5.85%) USD  |  NASDAQ  |  Mar 20, 16:00
1.78 -0.03 (-1.66%) After-Hours: 20:00
More

InspireMD Research and Development Expense (Quarterly) : 3.475M for Dec. 31, 2025

Research and Development Expense (Quarterly) Chart

View Research and Development Expense (Quarterly) for NSPR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

View Research and Development Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Quarterly) Benchmarks

View Research and Development Expense (Quarterly) Benchmarks
Start Trial
AngioDynamics, Inc. 7.768M
Lifeward Ltd. 0.843M
Abbott Laboratories 721.00M
Accuray, Inc. 10.65M
Plus Therapeutics, Inc. 2.941M